BeStock  

Oscar Health OSCR

US equityMarket cap rank #1633Healthcare Plans
$24.73 −$1.44 (-5.50%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $24.95 +0.89%
Open$26.10
Prev close$26.17
Day range$24.55 – $26.78
Volume6.61M
Market cap$7.68B
P/E (TTM)11.0
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$5.14B+72.1% YoY
Net profit$167.30M+221.7% YoY
Diluted EPS$0.49+192.5% YoY
Free cash flow-$1.21B-24.5% YoY
Operating cash flow-$1.20B

Revenue, last 8 quarters

$2.4BDec '24$3.0BMar '25$2.9BJun '25$3.0BSep '25$2.8BDec '25$4.6BMar '26$4.9BJun '26$5.1BSep '26

Net profit, last 8 quarters

$-153.3MDec '24$275.5MMar '25$-228.5MJun '25$-137.5MSep '25$-352.4MDec '25$679.0MMar '26$361.8MJun '26$167.3MSep '26

Diluted EPS by quarter

-0.62Dec '240.92Mar '25-0.89Jun '25-0.53Sep '25-1.24Dec '252.07Mar '261.10Jun '260.49Sep '26

Free cash flow by quarter

$340.0MDec '24$869.5MMar '25$499.8MJun '25$-973.7MSep '25$662.8MDec '25$2.6BMar '26$2.1BJun '26$-1.2BSep '26

Annual revenue

$589.6MFY20$1.9BFY21$4.1BFY22$5.9BFY23$9.2BFY24$11.7BFY25

Profitability & balance sheet

Net margin4.9%
Return on equity52.7%
Return on assets10.9%
Liabilities / assets77.8%
Total debt$432.41M
Free cash flow / sales23.7%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $5.14B $4.88B $4.65B $11.70B $2.81B
Total Operating Revenue $5.14B $4.88B $4.65B $11.70B $2.81B
Total Premiums Earned $5.04B $4.79B $4.58B $11.47B $2.75B
-Net Premiums Written $5.72B $5.66B $6.02B $14.07B $3.55B
-Increase Decrease in Net Unearned Premium Reserves -$677.30M -$871.47M -$1.44B -$2.60B -$803.30M
Fee Revenue and Other Income $6.30M $6.10M $5.72M $28.59M $8.97M
-Fees and Commissions $6.30M $6.10M $5.72M $0.00 -$19.63M
Net Investment Income $91.02M $84.79M $60.61M $202.94M $49.61M
Total Expenses $4.96B $4.50B $3.95B $12.14B $3.16B
Loss Adjustment Expense $4.23B $3.79B $3.23B $10.02B $2.62B
Selling and Admin Expenses $721.89M $176.94M $160.08M $2.05B $511.03M
Depreciation & Amortization $6.54M $6.06M $7.02M $28.89M $7.88M
$4.73M $4.71M $5.38M $17.60M -$1.10M
-Interest Expense Non-Operating $4.73M $4.71M $5.38M $17.60M -$1.10M
Other Operating Expenses -$2.09M $188.66M $196.44M $23.34M $20.03M
Pretax Profit $175.38M $383.01M $698.77M -$437.30M -$352.68M
Tax $8.08M $21.18M $19.75M $5.61M -$247,000.00
Net Profit $167.30M $361.83M $679.02M -$442.90M -$352.43M
Profit from Continuing Operations $167.30M $361.83M $679.02M -$442.90M -$352.43M
Minority Interests $23,000.00 $20,000.00 $27,000.00 $248,000.00 $177,000.00
Net Income to Parent Company $167.28M $361.81M $679.00M -$443.15M -$352.61M
Net Income to Common Stockholders $167.28M $365.53M $682.72M -$443.15M -$352.61M
Basic EPS $0.54 $1.20 $2.28 -$1.69 -$1.24
Diluted EPS $0.49 $1.10 $2.07 -$1.69 -$1.24
-General & Admin Expense – $176.94M $160.08M $2.05B $511.03M
Other Preferred Stock Dividends – -$3.72M -$3.72M – –
-Other Income Expense – – – $28.59M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $10.01B $11.23B $9.29B $6.33B $6.33B
Cash and Cash Equivalents $4.47B $4.08B $4.81B $2.77B $2.77B
Restricted Cash and Cash Equivalents $27.48M $29.18M $28.63M $32.95M $32.95M
Total Investments $4.46B $6.08B $3.26B $2.69B $2.69B
-Short Term Investments $3.02B $4.48B $1.99B $1.22B $1.22B
-Other Invested Assets $1.44B $1.60B $1.27B $1.47B $1.47B
Receivables $767.74M $757.35M $951.71M $598.46M $598.46M
-Accounts Receivable $767.74M $757.35M $951.71M $542.40M $542.40M
Net PPE $109.31M $101.49M $94.19M $88.35M $88.35M
Other Assets $173.95M $182.45M $148.56M $144.05M $144.05M
Total Liabilities $7.78B $9.17B $7.62B $5.34B $5.34B
Policy Holders Liabilities $160.39M $167.51M $172.00M $166.20M $166.20M
Payables $6.55B $8.00B $6.46B $4.05B $4.05B
-Accounts Payable $6.55B $8.00B $6.46B $1.46B $1.46B
Long Term Debt and Capital Lease Obligation $432.41M $431.63M $430.88M $430.10M $430.10M
-Long Term Debt $432.41M $431.63M $430.88M $430.10M $430.10M
Other Liabilities $638.54M $576.18M $557.31M $701.71M $701.71M
Total Equity $2.23B $2.06B $1.67B $980.74M $980.74M
Stockholders' Equity $2.22B $2.05B $1.66B $977.65M $977.65M
Capital Stock $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
-Common Stock $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
Additional Paid-In Capital $4.35B $4.32B $4.28B $4.26B $4.26B
Retained Earnings -$2.09B -$2.25B -$2.62B -$3.29B -$3.29B
Less: Treasury Stock -$2.92M -$2.92M -$2.92M -$2.92M -$2.92M
Gains/Losses Not Affecting Retained Earnings -$41.66M -$8.25M $5.00M $18.03M $18.03M
Minority Interests $3.16M $3.13M $3.11M $3.09M $3.09M
-Other Receivables – – – $56.07M $56.07M
-Other Payable – – – $2.59B $2.59B

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$1.20B $2.09B $2.62B $1.09B $671.90M
Net cash flow from continuing operations -$1.20B $2.09B $2.62B $1.09B $671.90M
Net Income from Continuing Operations $167.30M $361.83M $679.02M -$442.90M -$352.43M
Gain/Loss from Continuing Operations -$175,000.00 -$1.73M -$4,000.00 -$1.34M -$37,000.00
Deferred Tax $3.42M -$1.53M -$6.20M $2.45M $2.62M
Other Non-Cash Items -$36.17M $48.13M -$55,000.00 -$10.74M $13.28M
Change in Working Capital -$1.36B $1.67B $1.93B $1.46B $988.37M
-Change in Receivables -$3.34B $1.52B $1.64B $98.57M $99.07M
-Change in Loss and Loss Adjustment Expense Reserves $25.64M $164.38M $278.67M $98.66M -$109.01M
-Change in Payables and Accrued Expense $1.96B $19.87M -$474,000.00 $1.20B $906.59M
-Change in Unearned Premiums -$7.11M -$4.50M $5.80M $91.81M $89.09M
-Change in Other Current Assets $5.05M -$32.00M $5.34M -$27.12M $2.64M
Net cash flow from investing $1.58B -$2.83B -$590.25M -$241.06M -$48.71M
Net Cash Flow from Continuing Investing Activities $1.58B -$2.83B -$590.25M -$241.06M -$48.71M
Net PPE Purchase and Sale -$11.31M -$11.76M -$8.79M -$36.37M -$9.06M
Net Investment Purchase and Sale $1.59B -$2.82B -$580.60M -$208.96M -$40.69M
Net Other Investing Changes -$395,000.00 $1.47M -$860,000.00 $4.28M $1.05M
Financing Cash Flow $10.85M $13.30M -$3.60M $399.21M $8.17M
Net Cash Flow from Continuing Financing Activities $10.85M $13.30M -$3.60M $399.21M $8.17M
Proceeds from Stock Option Exercised $11.92M $28.77M $1.14M $55.03M $12.84M
Net Other Financing Charges -$1.07M -$15.47M -$4.74M -$65.82M -$4.67M
Ending Cash Balance $4.49B $4.10B $4.83B $2.80B $2.80B
Net Change in Cash $389.20M -$728.97M $2.03B $1.25B $631.37M
Beginning Cash Balance $4.10B $4.83B $2.80B $1.55B $2.17B
Free Cash Flow -$1.21B $2.08B $2.61B $1.06B $662.84M
Net Issuance Payments of Debt – – – $410.00M $0.00

Discussion

No comments yet — be the first to weigh in on OSCR.

Sign in to join the discussion.

Scroll to Top